# Impact of 18 FDG PET/CT on the Management of Patients With Staphylococcus Aureus Bloodstream Infection

> **NCT03419221** · NA · COMPLETED · sponsor: **University Hospital, Montpellier** · enrollment: 291 (actual)

## Conditions studied

- Staphylococcus Aureus

## Interventions

- **PROCEDURE:** PET/CT Positron emission tomography (PET) using small radiotracers, a special camera and a computer to evaluate organ and tissue functions
- **OTHER:** Patients' routine care with performance of explorations based on anamnesis and clinical symptoms

## Key facts

- **NCT ID:** NCT03419221
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-29
- **Primary completion:** 2025-03-20
- **Final completion:** 2025-03-20
- **Target enrollment:** 291 (ACTUAL)
- **Last updated:** 2025-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03419221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03419221, "Impact of 18 FDG PET/CT on the Management of Patients With Staphylococcus Aureus Bloodstream Infection". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03419221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*